Content Validity for Trial Endpoints: Using PFDD Guidance 2 to Identify What Matters
A methodological guide to FDA PFDD Guidance 2 for trial teams to elicit patient-reported disease and treatment burdens before assuming an existing questionnaire defines the concept of interest.
23 minBy
